President and Chief Executive Officer, IDEAYA Biosciences
Appears in 1 story
Leading the company toward its first FDA filing
IDEAYA Biosciences closed a $323.6 million stock sale on June 10, 2026. The cash lands as the company prepares to file its first drug with the U.S. Food and Drug Administration (FDA).
Updated Jun 10
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
